Evidence map›Paper›PMID 30629698›Full record

ArticlePLoS pathogens2019

Probing the impact of nairovirus genomic diversity on viral ovarian tumor domain protease (vOTU) structure and deubiquitinase activity.

John V Dzimianski, Brianna S Beldon, Courtney M Daczkowski, Octavia Y Goodwin, Florine E M Scholte, Éric Bergeron, Scott D Pegan

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Crimean-Congo haemorrhagic fever virus.Nature reviews. Microbiology · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

John V DzimianskiDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.
Brianna S BeldonDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.
Courtney M DaczkowskiDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.
Octavia Y GoodwinDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.
Florine E M ScholteViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-2110-3087
Éric BergeronViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-3398-8628
Scott D PeganDepartment of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-2958-5319
University of Georgia · USCenters for Disease Control and Prevention · US

Funding

Origin of the innate immunity suppression caused by nairovirus' protease activityR01AI109008 · NIAID · UNIVERSITY OF GEORGIA · PI PEGAN, SCOTT DUSAN · 2014 to 2018
$1.6M
Phase II SER-CAT Optimization: Acquisition of a next generation area detectorS10RR028976 · NCRR · UNIVERSITY OF GEORGIA · PI WANG, BI-CHENG · 2010 to 2010
$1.5M
Acquition of a microdiffractometer for SER-CATS10RR025528 · NCRR · UNIVERSITY OF GEORGIA · PI ROSE, JOHN PATRICK · 2009 to 2009
$414k
Acquisition of an X-ray Generator/Detector System to Support NIH ResearchS10OD021762 · OD · UNIVERSITY OF GEORGIA · PI ROSE, JOHN PATRICK · 2016 to 2016
$412k
NCRR NIH HHS S10 RR025528NCRR NIH HHS S10 RR028976NIAID NIH HHS R01 AI109008NIH HHS S10 OD021762
6 · The paper itself

Abstract

Post-translational modification of host and viral proteins by ubiquitin (Ub) and Ub-like proteins, such as interferon stimulated gene product 15 (ISG15), plays a key role in response to infection. Viruses have been increasingly identified that contain proteases possessing deubiquitinase (DUB) and/or deISGylase functions. This includes viruses in the Nairoviridae family that encode a viral homologue of the ovarian tumor protease (vOTU). vOTU activity was recently demonstrated to be critical for replication of the often-fatal Crimean-Congo hemorrhagic fever virus, with DUB activity suppressing the type I interferon responses and deISGylase activity broadly removing ISG15 conjugated proteins. There are currently about 40 known nairoviruses classified into fourteen species. Recent genomic characterization has revealed a high degree of diversity, with vOTUs showing less than 25% amino acids identities within the family. Previous investigations have been limited to only a few closely related nairoviruses, leaving it unclear what impact this diversity has on vOTU function. To probe the effects of vOTU diversity on enzyme activity and specificity, we assessed representative vOTUs spanning the Nairoviridae family towards Ub and ISG15 fluorogenic substrates. This revealed great variation in enzymatic activity and specific substrate preferences. A subset of the vOTUs were further assayed against eight biologically relevant di-Ub substrates, uncovering both common trends and distinct preferences of poly-Ub linkages by vOTUs. Four novel X-ray crystal structures were obtained that provide a biochemical rationale for vOTU substrate preferences and elucidate structural features that distinguish the vOTUs, including a motif in the Hughes orthonairovirus species that has not been previously observed in OTU domains. Additionally, structure-informed mutagenesis provided the first direct evidence of a second site involved in di-Ub binding for vOTUs. These results provide new insight into nairovirus evolution and pathogenesis, and further enhances the development of tools for therapeutic purposes.

Indexed as

Crystallography, X-RayDeubiquitinating EnzymesFemaleGenetic VariationGenomicsHumansNairovirusOvarian NeoplasmsOvaryPeptide HydrolasesPhylogenyProtein BindingProtein DomainsProtein Processing, Post-TranslationalProteolysisSequence Homology, Amino AcidDeubiquitinating EnzymesPeptide HydrolasesUbiquitinUbiquitinsViral Proteins

Identifiers

PMID30629698
PMCPMC6343935
OpenAlexW2905162518

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.